SYN-TECH Chem. & Pharm.'s latest marketcap:
As of 08/11/2025, SYN-TECH Chem. & Pharm.'s market capitalization has reached $109.39 M. According to our data, SYN-TECH Chem. & Pharm. is the 24335th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 109.39 M |
| Revenue (ttm) | 42.96 M |
| Net Income (ttm) | 10.01 M |
| Shares Out | 44.59 M |
| EPS (ttm) | 0.22 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 07/21/2025 |
| Earnings Date | 08/06/2025 |
SYN-TECH Chem. & Pharm.'s yearly market capitalization.
| Date | Market Cap(NT$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/11/2025 | NT$3.27 B | $109.39 M | -22.08% | 24335 |
| 12/31/2024 | NT$4.2 B | $127.91 M | 10.56% | 21721 |
| 12/29/2023 | NT$3.8 B | $123.59 M | 1.19% | 21700 |
| 12/30/2022 | NT$3.75 B | $122.59 M | 43.53% | 20973 |
| 12/30/2021 | NT$2.62 B | $94.36 M | 12.72% | 23487 |
| 12/31/2020 | NT$2.32 B | $82.5 M | -6.88% | 21705 |
| 12/31/2019 | NT$2.49 B | $83.18 M | 5.87% | 19088 |
| 12/28/2018 | NT$2.35 B | $76.87 M | 8.75% | 18665 |
| 12/29/2017 | NT$2.16 B | $72.83 M | -25.93% | 19655 |
| 12/30/2016 | NT$2.92 B | $89.93 M | 11.85% | 16413 |
Company Profile
About SYN-TECH Chem. & Pharm. Co., Ltd.
SYN-TECH Chem. & Pharm. Co., Ltd. is a leading manufacturer and supplier of active pharmaceutical ingredients (APIs), serving markets in Taiwan, Asia, Europe, the Americas, and internationally. Established in 1982, the company is headquartered in Tainan City, Taiwan.
Product Portfolio
SYN-TECH offers a diverse range of APIs across multiple therapeutic categories, including:
- Cardiovascular: Anticoagulant, antihypertensive, α-blocker, vasodilator
- Central Nervous System: ADHD treatment, anxiolytic, antidepressant, anticonvulsant, sedative
- Pain & Inflammation: Anti-inflammatory, antipyretic, analgesic, antimigraine
- Respiratory: Bronchodilator, antitussive, decongestant
- Gastrointestinal: Antiemetic, antiulcerative, antispasmodic
- Dermatological: Antipruritic, scabicide
- Urological: Treatment for benign prostatic hypertrophy and urinary frequency
- Other Specialties: Neuroprotective agents, antiglaucoma, hyponatremia treatment, Herpes virus inhibitors
Global Presence
With decades of experience, SYN-TECH has established a strong international presence, supplying high-quality APIs to pharmaceutical companies worldwide.
Frequently Asked Questions
-
What is SYN-TECH Chem. & Pharm.'s (TPEX-1777) current market cap?As of 08/11/2025, SYN-TECH Chem. & Pharm. (including the parent company, if applicable) has an estimated market capitalization of $109.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does SYN-TECH Chem. & Pharm. (TPEX-1777) rank globally by market cap?SYN-TECH Chem. & Pharm. global market capitalization ranking is approximately 24335 as of 08/11/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.